Quercetin

The reviewed onion-skin-extract trial found no significant blood-pressure effect in the whole cohort. A favorable hypertensive subgroup finding was exploratory.

A change in a laboratory marker, a test score and everyday function are different outcomes. A statistically detectable result does not by itself tell us whether someone would notice a worthwhile difference.

Check the measured endpoint, comparison and study population. The full profile preserves effect estimates and the source's clinical-significance assessment, including when that assessment is not supplied.

The claim to test: An exploratory subgroup establishes a general clinical benefit.

What the reviewed records say:

The gap: Multiple comparisons, subgroup membership changes and per-protocol analysis limit inference. Other formulations, studies and long-term safety require review.

Durability, effects in other populations and healthy-lifespan outcomes need their own evidence.

Independent replication, meaningful human outcomes, longer follow-up and better safety reporting would make these results easier to interpret.

Multiple comparisons, subgroup membership changes and per-protocol analysis limit inference. Other formulations, studies and long-term safety require review.